Drug Shortage Report for DANTROLENE SODIUM FOR INJECTION, USP
| Report ID | 269095 |
| Drug Identification Number | 02529998 |
| Brand name | DANTROLENE SODIUM FOR INJECTION, USP |
| Common or Proper name | DANTROLENE SODIUM FOR INJECTION, USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DANTROLENE SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 6X20MG |
| ATC code | M03CA |
| ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-10-23 |
| Actual start date | |
| Estimated end date | 2026-03-01 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT, SUITE 1050 MISSISSAUGA, ONTARIO CANADA L5R 0G3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-10-24 | English | Compare |
| v2 | 2025-10-09 | French | Compare |
| v1 | 2025-10-09 | English | Compare |
Showing 1 to 3 of 3